Status of Active Specific Immunotherapy for Stage II, Stage III, and Resected Stage IV Colon Cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Oncology,Hepatology
Link
http://link.springer.com/content/pdf/10.1007/s11888-013-0182-5.pdf
Reference95 articles.
1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11–30.
2. Okuno K, Sugiura F, Itoh K, Yoshida K, Tsunoda T, Nakamura Y. Recent advances in active specific cancer vaccine treatment for colorectal cancer. Curr Pharm Biotechnol. 2012;13:1439–45.
3. Uyl-de Groot CA, Vermorken JB, Hanna MG, et al. Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits. Vaccine. 2005;23:2379–87.
4. • Speetjens FM, Zeestraten EC, Kuppen PJ, Melief CJ, van der Burg SH. Colorectal cancer vaccines in clinical trials. Expert Rev Vaccines. 2011;10:899–921. The authors elucidate current strategies of ASI for CRC patients with a focus on T-cell-mediated immunotherapy. They refer to clinical trials using either tumor-cell-derived vaccines or tumor antigen vaccines.
5. Hellinger MD, Santiago CA. Reoperation for recurrent colorectal cancer. Clin Colon Rectal Surg. 2006;19:228–36.
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Development, Optimization, and in vitro Evaluation of Silybin-loaded PLGA Nanoparticles and Decoration with 5TR1 Aptamer for Targeted Delivery to Colorectal Cancer Cells;AAPS PharmSciTech;2024-06-19
2. Prognostic and clinicopathological value of MUC1 expression in colorectal cancer;Medicine;2019-03
3. Self-antigen MASH2 combined with the AS15 immunostimulant induces tumor protection in colorectal cancer mouse models;PLOS ONE;2019-01-25
4. Immunological Treatment in Gastrointestinal Cancers;Textbook of Gastrointestinal Oncology;2019
5. Cell Based Therapy: Modified Cancer Cells;Immunotherapy for Gastrointestinal Cancer;2017
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3